Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › San Antonio › NPI 1003835133
Physician

Premier Pain Consultants, PLLC

Premier Pain Consultants, PLLC was paid $4K by Medicaid between Jan 2018 and Sep 2018, across 5 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 54% of everything it billed.

33Billing provider infoPREMIER PAIN CONSULTANTS, PLLC
SAN ANTONIO, TX 78229
33aNPI1003835133assigned 07/19/2006
28Total paid$4K
24GClaims748
24DCodes billed5
24AFirst – last monthJan 2018 – Sep 2018
Compared with peers

Next to other Pain Medicine (Anesthesiology) Physician providers in Texas

Rank by total paid#39 of 64
Median peer was paid$7K
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018748$4K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 54% 161 152 $2K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 46% 260 249 $2K
96127 0% 18 17 $0.00
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 0% 155 148 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 0% 154 147 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBUYANOV, DMITRIY (PRESIDENT)